Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × Blood Specimen Collection × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 43 Neoplasms 28 Colorectal Neoplasms 20 Prostatic Neoplasms 12 Neoplastic Cells, Circulating 11 Melanoma 11 Multiple Myeloma 10 Lung Neoplasms 10 Pancreatic Neoplasms 9 Uterine Cervical Neoplasms 7 Ovarian Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Papillomavirus Infections 5 Neoplasm Metastasis 5 Lymphoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 COVID-19 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Liver Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3

Interventions

Cyclophosphamide 42 Etoposide 28 Filgrastim 27 Carboplatin 23 Doxorubicin 22 Melphalan 21 Isotretinoin 21 Vincristine 19 Topotecan 19 Granulocyte Colony-Stimulating Factor 19 Peripheral Blood Stem Cell Transplantation 17 Irinotecan 16 Cisplatin 15 sargramostim 14 Temozolomide 14 3-Iodobenzylguanidine 12 Radiotherapy 11 humanized 3F8 anti-GD2 monoclonal antibody 10 Granulocyte-Macrophage Colony-Stimulating Factor 10 dinutuximab 8 Busulfan 8 Interleukin-2 7 etoposide phosphate 6 aldesleukin 6 Stem Cell Transplantation 6 Vorinostat 5 Thiotepa 5 Polymerase Chain Reaction 5 Methylprednisolone 5 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02864563 2023-12-01

PHRCNB07

Institut Curie

Phase NA Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡